Concepedia
Statistics
Publications
9
Citations
910
H-Index
Active since
2012
Affiliations
Roche (Switzerland)(Current)
University of Southern California
Children's Hospital of Los Angeles
Washington University in St. Louis
City of Hope
Michelle Y. Doral is an author at Roche (Switzerland) specializing in medicine, oncology, and hematologic oncology.
Publications per year
2012–2024
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
Guy Young, Ri Liesner, Tiffany Chang et al. · Blood · 2019 · 384 citations · Full text
Medicine, Hematology, Pharmacology +6
Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia
Sarah K. Tasian, Michelle Y. Doral, Michael J. Borowitz et al. · Blood · 2012 · 244 citations
Life Sciences, Molecular Biology, Oncology +8
Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)
Margaret Zhou, Michelle Y. Doral, Steven G. DuBois et al. · European Journal of Cancer · 2015 · 66 citations
Medicine, Nuclear Medicine, Oncology +6
Mosunetuzumab Shows Promising Efficacy in Patients with Multiply Relapsed Follicular Lymphoma: Updated Clinical Experience from a Phase I Dose-Escalation Trial
Sarit Assouline, Won Seog Kim, Laurie H. Sehn et al. · Blood · 2020 · 59 citations
Medicine, Oncology, Pharmacotherapy +12
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies
Rebecca Kruse‐Jarres, Flora Peyvandi, Johannes Oldenburg et al. · Blood Advances · 2022 · 52 citations · Full text
Medicine, Hematology, Surgery +15
1–5 of 9